The NLRP3 inflammasome pathway of innate immunity has been implicated in the pathophysiology of both gout and ASCVD.9, 10, 11 The inflammasome and downstream cytokines have thus become a therapeutic target for both diseases. The gene discussed is NLRP3; the disease is gout.